Yanna Jiao

658 total citations
21 papers, 510 citations indexed

About

Yanna Jiao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yanna Jiao has authored 21 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Yanna Jiao's work include Immune cells in cancer (4 papers), Phytochemistry and Bioactive Compounds (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yanna Jiao is often cited by papers focused on Immune cells in cancer (4 papers), Phytochemistry and Bioactive Compounds (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Yanna Jiao collaborates with scholars based in China and Ethiopia. Yanna Jiao's co-authors include Huifeng Hao, Pingping Li, Shuyan Han, Shuyan Han, Jialei Fu, Shan Wang, Shantong Jiang, Changcai Bai, Xinxin Deng and Xiran He and has published in prestigious journals such as Biochemical Pharmacology, Journal of Ethnopharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Yanna Jiao

20 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanna Jiao China 10 256 107 105 103 65 21 510
Chunpu Zou China 12 258 1.0× 80 0.7× 86 0.8× 80 0.8× 42 0.6× 24 458
Hae‐Ran Park South Korea 17 213 0.8× 72 0.7× 88 0.8× 125 1.2× 47 0.7× 47 628
Yunong Li China 9 248 1.0× 100 0.9× 79 0.8× 104 1.0× 52 0.8× 14 521
Zhichao Xi China 15 320 1.3× 95 0.9× 123 1.2× 55 0.5× 72 1.1× 35 574
Fengjun Cao China 16 355 1.4× 136 1.3× 127 1.2× 63 0.6× 46 0.7× 23 589
Xinxin Deng China 12 205 0.8× 93 0.9× 110 1.0× 66 0.6× 53 0.8× 36 504
Deok Yong Sim South Korea 15 332 1.3× 123 1.1× 100 1.0× 57 0.6× 34 0.5× 39 497
Xiumei Gao China 11 329 1.3× 62 0.6× 94 0.9× 67 0.7× 65 1.0× 20 556
Jing‐Xuan Bai Hong Kong 14 240 0.9× 51 0.5× 92 0.9× 77 0.7× 65 1.0× 31 497

Countries citing papers authored by Yanna Jiao

Since Specialization
Citations

This map shows the geographic impact of Yanna Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanna Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanna Jiao more than expected).

Fields of papers citing papers by Yanna Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanna Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanna Jiao. The network helps show where Yanna Jiao may publish in the future.

Co-authorship network of co-authors of Yanna Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yanna Jiao. A scholar is included among the top collaborators of Yanna Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanna Jiao. Yanna Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xinxin, Yanna Jiao, Huifeng Hao, et al.. (2025). Dandelion extract suppresses the stem-like properties of triple-negative breast cancer cells by regulating CUEDC2/β-catenin/OCT4 signaling axis. Journal of Ethnopharmacology. 342. 119408–119408. 3 indexed citations
2.
Hao, Huifeng, Shengtao Zhou, Yanna Jiao, et al.. (2025). Targeting the CXCR7 pathway with TC14012 to inhibit endothelial necroptosis and lung cancer metastasis. Biochemical Pharmacology. 236. 116852–116852. 5 indexed citations
3.
Zhou, Shengtao, Xinrui Li, Yanna Jiao, et al.. (2025). Hedyotis diffusa Willd. inhibits pulmonary metastasis of cancer through suppression of Src/FAK signaling. Phytomedicine. 150. 157673–157673.
5.
6.
Tian, Zhihua, Huifang Tian, Haibo Han, et al.. (2023). HDGF promotes gefitinib resistance by activating the PI3K/AKT and MEK/ERK signaling pathways in non-small cell lung cancer. Cell Death Discovery. 9(1). 181–181. 14 indexed citations
7.
Deng, Xinxin, Shan Wang, Yuan Yuan, et al.. (2023). SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages. International Journal of Biological Macromolecules. 254(Pt 1). 127639–127639. 7 indexed citations
8.
Hao, Huifeng, et al.. (2022). Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF. Journal of Ethnopharmacology. 298. 115607–115607. 20 indexed citations
9.
Hao, Huifeng, Zhandong Li, Junfeng Li, et al.. (2022). Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4. Phytomedicine. 106. 154409–154409. 6 indexed citations
10.
Wang, Shan, Huifeng Hao, Yanna Jiao, et al.. (2022). Dandelion extract inhibits triple-negative breast cancer cell proliferation by interfering with glycerophospholipids and unsaturated fatty acids metabolism. Frontiers in Pharmacology. 13. 942996–942996. 24 indexed citations
12.
Wang, Shan, Jialei Fu, Huifeng Hao, et al.. (2021). Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacological Research. 170. 105728–105728. 136 indexed citations
13.
Hao, Huifeng, Haiyu Zhao, Wei Ren, et al.. (2020). Marsdenia tenacissima extract promotes gefitinib accumulation in tumor tissues of lung cancer xenograft mice via inhibiting ABCG2 activity. Journal of Ethnopharmacology. 255. 112770–112770. 10 indexed citations
14.
Deng, Xinxin, Xinqi Liu, Lu Han, et al.. (2020). Polygala tenuifolia: a source for anti-Alzheimer’s disease drugs. Pharmaceutical Biology. 58(1). 410–416. 57 indexed citations
15.
Li, Zhandong, Huifeng Hao, Yanna Jiao, et al.. (2019). Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MTE). Journal of Ethnopharmacology. 250. 112524–112524. 9 indexed citations
16.
Hao, Huifeng, Chun‐Shui Pan, Yanna Jiao, et al.. (2019). Marsdenia tenacissima extract dilated small mesenteric arteries via stimulating endothelial nitric oxide synthase and inhibiting calcium influx. Journal of Ethnopharmacology. 238. 111847–111847. 5 indexed citations
17.
Jiao, Yanna, Lina Wu, Dong Xue, et al.. (2018). Marsdenia tenacissima extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells. Cancer Cell International. 18(1). 149–149. 52 indexed citations
18.
Jiang, Shantong, et al.. (2018). Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1. International Journal of Molecular Medicine. 41(4). 2128–2138. 7 indexed citations
20.
Ma, Qiang, Yanna Jiao, Shanshan Yan, et al.. (2015). Targeting of NHERF1 through RNA interference inhibits the proliferation and migration of metastatic prostate cancer cells. Oncology Letters. 11(2). 1149–1154. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026